Brown Advisory, an investment management company, released its “Brown Advisory Mid-Cap Growth Strategy” third-quarter 2025 ...
Discover why DexCom (DXCM) could rebound in 2025. Explore buyback plans, growth potential, and investment insights in the ...
Senseonics earns a buy with Eversense 365 driving growth, Q3 revenue up 90% YoY, gross margin expansion, and Ascensia ...
One of the Apple Watch’s biggest threats has no screen, weighs about a fifth of an ounce and charges a monthly subscription ...
It's true Oura partners with Palantir Technologies, a software company that serves the U.S. government. But some claims about ...
Indiana Wish has granted 3,600 wishes to kids with a life-threatening diagnosis, and provided one Indiana girl with a dog ...
Healthtech startup EVYA blends non-invasive sensing with AI-led insights to help users understand glucose stability, energy ...
Founded in 1989 to solve the "unsolvable problem" of accurate pulse oximetry during patient movement, Masimo (NASDAQ:MASI) ...
Zacks.com on MSN
4 Medical Device Stocks to Buy for Healthy Returns in 2026
PODD holds a Zacks Rank #2. For 2026, its revenues and EPS are expected to grow 19.8% and 26.3%, respectively. The company’s ...
GlucoModicum today unveiled Sofio, which it labels the world's first needle-free glucose monitor based on ...
Abbott (NYSE:ABT) announced today that it made its Lingo over-the-counter continuous glucose monitor (CGM) available at Walgreens.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback